0.8371
Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten
What drives Galmed Pharmaceuticals Ltd stock priceAutomated Trading Signals & Free Unlock Hidden Market Opportunities - earlytimes.in
Key metrics from Galmed Pharmaceuticals Ltd.’s quarterly dataJuly 2025 Sector Moves & Verified Stock Trade Ideas - newser.com
Can swing trading help recover from Galmed Pharmaceuticals Ltd. lossesTrade Ideas & Daily Profit Maximizing Tips - newser.com
Is Galmed Pharmaceuticals Ltd. (GPH) stock resilient in recession scenarios - newser.com
Is Galmed Pharmaceuticals Ltd. (GPH) stock good for long term investingMarket Performance Report & Free Safe Entry Trade Signal Reports - newser.com
Is Galmed Pharmaceuticals Ltd. (GPH) stock suitable for passive index fundsWeekly Trading Summary & Verified Momentum Watchlists - newser.com
Why Galmed Pharmaceuticals Ltd. stock attracts global investorsWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com
Galmed Pharmaceuticals Reveals Promising Results in Oncology Drug Combination Study - MSN
How buyback programs support Galmed Pharmaceuticals Ltd. (GPH) stock2025 Macro Impact & AI Enhanced Trading Alerts - newser.com
Views of Wall Street’s Leading Experts on Galmed Pharmaceuticals Ltd - Setenews
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study - TipRanks
Galmed announces meaningful top line results from AM-001 study of Aramchol meglumine - MarketScreener
Galmed (NASDAQ: GLMD) AM-001 shows 5-fold, 3-fold Aramchol bioavailability improvement - Stock Titan
Galmed reports 3-drug combo enhances cancer treatment efficacy By Investing.com - Investing.com Canada
Is Galmed Pharmaceuticals Ltd. (GPH) stock positioned for digital growth eraTrade Volume Summary & Fast Moving Market Watchlists - newser.com
Is It Time to Reconsider Galmed Stock? - StocksToTrade
Galmed Pharmaceuticals Ltd. (GLMD) Stock: Soars 10.85% Following Breakthrough Cancer Treatment Results - parameter.io
NASDAQ:GLMD News 17 November 2025 - ts2.tech
Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025 - ts2.tech
Galmed stock soars after promising cancer treatment research results By Investing.com - Investing.com Nigeria
Galmed Pharmaceuticals: Is It A Turnaround Story? - timothysykes.com
Galmed stock soars after promising cancer treatment research results - Investing.com
Galmed reports 3-drug combo enhances cancer treatment efficacy - Investing.com
Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro - WV News
How Galmed Pharmaceuticals Ltd. stock performs after earningsBreakout Watch & Risk Adjusted Swing Trade Ideas - newser.com
How Galmed Pharmaceuticals Ltd. stock reacts to inflationary pressuresTrade Risk Summary & Comprehensive Market Scan Insights - newser.com
Galmed Pharmaceuticals Ltd Stock Analysis and ForecastResistance Breakout Alerts & Rapid Wealth Accumulation - earlytimes.in
Why Galmed Pharmaceuticals Ltd. stock is trending among retail traders2025 Volatility Report & AI Driven Stock Movement Reports - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):